J.P. Lobelle

1.1k total citations
25 papers, 794 citations indexed

About

J.P. Lobelle is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, J.P. Lobelle has authored 25 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in J.P. Lobelle's work include Breast Cancer Treatment Studies (9 papers), Estrogen and related hormone effects (7 papers) and Frailty in Older Adults (6 papers). J.P. Lobelle is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Estrogen and related hormone effects (7 papers) and Frailty in Older Adults (6 papers). J.P. Lobelle collaborates with scholars based in Belgium, Netherlands and United Kingdom. J.P. Lobelle's co-authors include Martine Piccart, Robert Paridaens, M. Nooij, Laura Biganzoli, Caroline Lohrisch, F. Ries, David Cameron, Luc Dirix, L.V.A.M. Beex and Tanja Čufer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

J.P. Lobelle

25 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Lobelle Belgium 12 521 343 294 134 117 25 794
A. Elise van Leeuwen‐Stok Netherlands 11 411 0.8× 393 1.1× 104 0.4× 44 0.3× 231 2.0× 24 756
Isabelle Van Praagh France 12 452 0.9× 327 1.0× 53 0.2× 93 0.7× 190 1.6× 23 908
Laurence Venat‐Bouvet France 14 366 0.7× 181 0.5× 61 0.2× 96 0.7× 138 1.2× 40 647
Lauren K. Brais United States 17 902 1.7× 235 0.7× 128 0.4× 246 1.8× 99 0.8× 39 1.3k
Mahesh Parmar United Kingdom 9 357 0.7× 172 0.5× 104 0.4× 165 1.2× 337 2.9× 12 1.5k
Claire Snowdon United Kingdom 8 792 1.5× 454 1.3× 651 2.2× 184 1.4× 250 2.1× 15 1.2k
Davide Lombardi Italy 17 609 1.2× 211 0.6× 97 0.3× 210 1.6× 308 2.6× 57 1.0k
Lindsay Carlsson Canada 9 324 0.6× 215 0.6× 288 1.0× 73 0.5× 126 1.1× 25 667
Gabriele Martelli Italy 19 501 1.0× 807 2.4× 109 0.4× 62 0.5× 98 0.8× 44 1.2k
J. Wendall Goodwin United States 16 522 1.0× 102 0.3× 55 0.2× 186 1.4× 334 2.9× 34 1.0k

Countries citing papers authored by J.P. Lobelle

Since Specialization
Citations

This map shows the geographic impact of J.P. Lobelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Lobelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Lobelle more than expected).

Fields of papers citing papers by J.P. Lobelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Lobelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Lobelle. The network helps show where J.P. Lobelle may publish in the future.

Co-authorship network of co-authors of J.P. Lobelle

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Lobelle. A scholar is included among the top collaborators of J.P. Lobelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Lobelle. J.P. Lobelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Decoster, Lore, Chantal Quinten, Cindy Kenis, et al.. (2018). Quality of life (QoL) in older patients (pts) with cancer and prognostic factors for QoL decline.. Journal of Clinical Oncology. 36(15_suppl). 10010–10010. 2 indexed citations
3.
Decoster, Lore, Cindy Kenis, Johan Flamaing, et al.. (2017). Adherence to geriatric assessment (GA)-based recommendations in older patients (pts) with cancer.. Journal of Clinical Oncology. 35(15_suppl). 10010–10010. 1 indexed citations
4.
Decoster, Lore, Cindy Kenis, Hans Prenen, et al.. (2016). Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer. Clinical Colorectal Cancer. 16(3). e221–e229. 25 indexed citations
5.
Kenis, Cindy, Pieter Heeren, Lore Decoster, et al.. (2014). Implementation of geriatric assessment in older patients with cancer: Facilitators and barriers. Journal of Geriatric Oncology. 5. S55–S56. 1 indexed citations
6.
Kenis, Cindy, Katrien Van Puyvelde, Johan Flamaing, et al.. (2013). IMPACT OF GERIATRIC ASSESSMENT ON TREATMENT DECISIONS IN OLDER LUNG CANCER PATIENTS. Journal of Thoracic Oncology. 8. 2 indexed citations
7.
Kenis, Cindy, Lore Decoster, Jacques De Grève, et al.. (2013). Performance of two geriatric screening tools in older cancer patients. European Journal of Cancer. 49. 6 indexed citations
8.
Decoster, Lore, Cindy Kenis, Katrien Van Puyvelde, et al.. (2013). The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer. Journal of Geriatric Oncology. 4(3). 235–241. 54 indexed citations
9.
Wildiers, Hans, et al.. (2009). A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis. Annals of Oncology. 21(2). 419–423. 16 indexed citations
10.
Wildiers, Hans, et al.. (2009). A double blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel induced dacryostenosis.. Cancer Research. 69(2_Supplement). 6144–6144. 1 indexed citations
11.
Brouwers, Barbara, Robert Paridaens, J.P. Lobelle, et al.. (2008). Clinicopathological Features of Inflammatory versus Noninflammatory Locally Advanced Nonmetastatic Breast Cancer. Tumor Biology. 29(4). 211–216. 10 indexed citations
12.
Focan, C., Marie-Pascale Graas, M. Beauduin, et al.. (2005). Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial.. PubMed. 25(2B). 1211–7. 4 indexed citations
13.
Paridaens, Robert, Luc Dirix, Caroline Lohrisch, et al.. (2003). Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Annals of Oncology. 14(9). 1391–1398. 172 indexed citations
14.
15.
Focan, C., M. Beauduin, E. Salamon, et al.. (2001). Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. British Journal of Cancer. 85(1). 1–8. 27 indexed citations
16.
Leo, Angelo Di, Denis Larsimont, David Gancberg, et al.. (2001). HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide. Annals of Oncology. 12(8). 1081–1089. 87 indexed citations
17.
Focan, C., Françis Lévi, F. Kreutz, et al.. (1999). Continuous delivery of venous 5-fluorpuracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer. Anti-Cancer Drugs. 10(4). 385–392. 16 indexed citations
18.
Focan, C., M. Beauduin, E. Salamon, et al.. (1998). P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial. European Journal of Cancer. 34. S40–S40. 2 indexed citations
19.
Focan, C, Marie-Thérèse Closon, Mario Dicato, et al.. (1993). Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial.. Journal of Clinical Oncology. 11(7). 1253–1263. 99 indexed citations
20.
Focan, C., A Baudoux, M. Beauduin, et al.. (1989). Adjuvant Treatment with High Dose Medroxyprogesterone Acetate in Node-Negative Early Breast Cancer A 3-year Interim Report on a Randomized Trial (I). Acta Oncologica. 28(2). 237–240. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Elise van Leeuwen‐Stok Breakdown of academic impact, for papers by Isabelle Van Praagh Breakdown of academic impact, for papers by Laurence Venat‐Bouvet Breakdown of academic impact, for papers by Lauren K. Brais Breakdown of academic impact, for papers by Mahesh Parmar Breakdown of academic impact, for papers by Claire Snowdon Breakdown of academic impact, for papers by Davide Lombardi Breakdown of academic impact, for papers by Lindsay Carlsson Breakdown of academic impact, for papers by Gabriele Martelli Breakdown of academic impact, for papers by J. Wendall Goodwin
Rankless by CCL
2026